$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Delayed/sustained release of macromolecules 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/24
출원번호 US-0866042 (1986-05-22)
발명자 / 주소
  • Sanders Lynda M. (Palo Alto CA) Domb Abraham (Brookline MA)
출원인 / 주소
  • Syntex (U.S.A.) Inc. (Palo Alto CA 02)
인용정보 피인용 횟수 : 298  인용 특허 : 21

초록

This invention concerns novel, delayed/sustained release devices and compositions, including methods of their manufacture and use. The compositions include macromolecules, particularly polypeptide pharmaceuticals, and an initially partially-hydrated, non-biodegradable, hydrogel rate-limiting membran

대표청구항

A drug delivery device for the controlled administration of a macromolecular drug, said device comprising: (a) a pharmaceutically acceptable carrier; (b) a macromolecular drug having a molecular weight greater than about 1,000 mixed with said carrier; and (c) an initially partially-hydrated, non-bio

이 특허에 인용된 특허 (21) 인용/피인용 타임라인 분석

  1. Schally Andrew V. (2500 Whitney Place ; Apt. 319 ; Bldg. 2 Metairie LA 70002) Coy David H. (4319 Perrier St. New Orleans LA 70115), (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates.
  2. Kent John S. (Palo Alto CA), Cholesterol matrix delivery system for sustained release of macromolecules.
  3. Mueller, Karl F.; Heiber, Sonia J., Crosslinked, porous polymers for controlled drug delivery.
  4. Michelson Paul E. (2280 Calle Tiara La Jolla CA 92037), Delivery system for desired agents.
  5. Wong Patrick S. (Hayward CA), Device for delivering agent in vagina.
  6. Higuchi ; Takeru ; Hussain ; Anwar, Drug-delivery device comprising certain polymeric materials for controlled release of drug.
  7. Zaffaroni Alejandro (Atherton CA), Microporous drug delivery device.
  8. Chien Yie W. (Skokie IL) Lambert Howard J. (Deerfield IL), Microsealed pharmaceutical delivery device.
  9. Nestor ; Jr. John J. (San Jose CA) Vickery Brian H. (Saratoga CA), Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists.
  10. Zaffaroni Alejandro (Atherton CA), Novel drug delivery device.
  11. Arnold Randall K. (San Jose CA), Ocular drug delivery device.
  12. Gale Robert M. (Mt. View CA) Ben-Dor Monique (Palo Alto CA) Keller Nancy (Palo Alto CA), Ocular therapeutic system for dispensing a medication formulation.
  13. Higuchi Takeru (Lawrence KS) Hussain Anwar (Lexington KY), Ocular therapeutic system manufactured from copolymer.
  14. Himmelstein Kenneth J. (Lawrence KS), Osmotic drug delivery system.
  15. Ronel Samuel H. (Princeton NJ) D\Andrea Mark J. (Neshanic Station NJ) Dobelle William H. (New York NY) Klomp Gregory F. (New York NY) Hashiguchi Hiroshi (Riverdale NY), Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue an.
  16. Bawa Rajan (Fairport NY), Sustained-release formulation containing and amino acid polymer.
  17. Theeuwes Felix (Los Altos CA), System with microporous releasing diffusor.
  18. Folkman Moses J. (Brookline MA) Langer ; Jr. Robert S. (Allston MA), Systems for the controlled release of macromolecules.
  19. Wong ; Patrick S. L. ; Smith ; Kelly L. ; Michaels ; Alan S., Therapeutic systems made from certain segmented copolyesters.
  20. Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Topical composition containing steroid in two forms released independently from polymeric carrier.
  21. Schally Andrew V. (2500 Whitney Place ; Apt. 319 Metairie LA 70002) Coy David H. (3823 B. St. Charles Ave. New Orleans LA 70115), [D-Trp6]-LH-RH and intermediates therefor.

이 특허를 인용한 특허 (298) 인용/피인용 타임라인 분석

  1. Zhang, Sheng; Ruiz, Rafael, Adhesive compositions for medical use: single additive as both the thickening agent and the accelerator.
  2. Bialer Meir,ILX ; Dagan Arie,ILX ; Sherbel Sussan,ILX, Anticonvulsant drugs and pharmaceutical compositions thereof.
  3. Chappa, Ralph A.; Bach, Andrew G.; MacGregor, Mark, Apparatus and methods for coating medical devices.
  4. Chappa, Ralph A.; Bach, Andrew G.; MacGregor, Mark, Apparatus and methods for coating medical devices.
  5. Chappa, Ralph A.; Bach, Andrew G.; MacGregor, Mark, Apparatus and methods for coating medical devices.
  6. Chappa, Ralph A.; Bach, Andrew G.; MacGregor, Mark, Apparatus and methods for coating medical devices.
  7. Humayun, Mark S.; Caffey, Sean, Apparatus and methods for delivering therapeutic agents.
  8. Humayun, Mark S.; Caffey, Sean, Apparatus and methods for delivering therapeutic agents.
  9. Humayun, Mark; Caffey, Sean, Apparatus and methods for delivering therapeutic agents.
  10. Chang, James N., Apparatus and methods for implanting particulate ocular implants.
  11. Weber,David A.; Kane,Ingrid; Rehal,Mike; Lathrop, III,Robert L.; Aptekarev,Kenny; Etter,Jeffrey; Gerondale,Scott; Bhagat,Rahul; Davis,Shawn, Apparatus for delivery of ocular implants.
  12. Weber,David; Kane,Ingrid; Rehal,Mike; Lathrop, III,Robert L.; Aptekarev,Kenny, Apparatus for delivery of ocular implants.
  13. Naidu, Kamatham A., Ascorbyl esters for the treatment of cancer.
  14. Tan, Jun; Town, Terrence; Mullan, Michael, Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology.
  15. Chudzik, Stephen J.; Anderson, Aron B.; Chappa, Ralph A.; Kloke, Timothy M., Bioactive agent release coating.
  16. Chudzik,Stephen J.; Anderson,Aron B.; Chappa,Ralph A.; Kloke,Timothy M., Bioactive agent release coating.
  17. Chudzik,Stephen J.; Anderson,Aron B.; Chappa,Ralph A.; Kloke,Timothy M., Bioactive agent release coating.
  18. Chappa, Ralph A.; Hergenrother, Robert W.; Anderson, Aron B.; Tran, Linh V.; Lawin, Laurie R.; Ofstead, Ronald F., Bioactive agent release coating and controlled humidity method.
  19. Chappa,Ralph A.; Hergenrother,Robert W.; Anderson,Aron B.; Tran,Linh V.; Lawin,Laurie R.; Ofstead,Ronald F., Bioactive agent release coating and controlled humidity method.
  20. Koeda, Hiroshi, Biochip, reactor, and reaction method.
  21. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  22. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  23. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  24. Masters, David B.; Berg, Eric Peter, Biomatrix structural containment and fixation systems and methods of use thereof.
  25. Katti, Kattesh V.; Gali, Hariprasad; Volkert, Wynn A., Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents.
  26. Chang, James N.; Hughes, Patrick M.; Devries, Gerald W., Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems.
  27. DeWitt, David M.; Finley, Michael J.; Lawin, Laurie R., Coating compositions for bioactive agents.
  28. DeWitt, David M.; Finley, Michael J.; Lawin, Laurie R., Coating compositions for bioactive agents.
  29. Reyes, Joe, Composition to boost libido.
  30. de Mollerat du Jeu, Xavier; Andronikou, Nektaria, Compositions and methods for efficient delivery of molecules to cells.
  31. Hughes, Patrick M.; Olejnik, Orest; Whitcup, Scott M.; Burke, James A., Compositions and methods for localized therapy of the eye.
  32. Sanders, Steven W.; Ebert, Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  33. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  34. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  35. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  36. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  37. Sanders,Steven W.; Ebert,Charles D., Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy.
  38. Trogden, John T.; Salameh, Adnan K.; Pujara, Chetan P., Compositions and methods for stimulating hair growth.
  39. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
  40. Ebert,Charles D.; Sanders,Steven W., Compositions and methods for transdermal oxybutynin therapy.
  41. Kuzma, Petr, Compositions and methods for treating precocious puberty.
  42. Brasch, Michael; Cheo, David; Hartley, James; Temple, Gary, Compositions for use in recombinational cloning of nucelic acids.
  43. Hartley, James L.; Brasch, Michael A.; Temple, Gary F.; Cheo, David, Compositions for use in recombinational cloning of nucleic acids.
  44. Hartley, James; Brasch, Michael; Temple, Gary; Cheo, David, Compositions for use in recombinational cloning of nucleic acids.
  45. Li, Jianmin; Bucay Couto, Weenna, Controlled drug delivery.
  46. Anderson, Aron B.; Lawin, Laurie R.; Shen, Byron C.; de Juan, Eugene; Varner, Signe E.; Chappa, Ralph A., Controlled release bioactive agent delivery device.
  47. Anderson, Aron B.; Lawin, Laurie R.; Shen, Byron C.; de Juan, Eugene; Varner, Signe E.; Chappa, Ralph A., Controlled release bioactive agent delivery device.
  48. Anderson, Aron B.; Lawin, Laurie R.; Shen, Byron C.; de Juan, Eugene; Varner, Signe E.; Chappa, Ralph A., Controlled release bioactive agent delivery device.
  49. Anderson, Aron B.; Lawin, Laurie R.; Shen, Byron C.; de Juan, Eugene; Varner, Signe E.; Chappa, Ralph A., Controlled release bioactive agent delivery device.
  50. Kuzma, Petr; Decker, Stefanie, Controlled release formulations of octreotide.
  51. Kuzma, Petr; Decker, Stephanie, Controlled release formulations of octreotide.
  52. Chandrashekar Bhagya L. ; Zhou Mingxing ; Jarr Eileen M. ; Dunn Richard L., Controlled release liquid delivery compositions with low initial drug burst.
  53. Wong Vernon G. ; Hu Mae W. L. ; Berger ; Jr. Donald E., Controlled-release biocompatible ocular drug delivery implant devices and methods.
  54. Zhang, Sheng; Azevedo, Max; Ruiz, Sr., Rafael, Curing accelerator and method of making.
  55. Zhang, Sheng; Ruiz, Sr., Rafael; Azevedo, Max, Curing accelerator and method of making.
  56. Lee, Jeoung Soo; Webb, Charles Kenneth; Zimmerman, Robert; Ruiz, Sr., Rafael, Cyanoacrylate tissue adhesives.
  57. Lee, Jeoung Soo; Webb, Charles Kenneth; Zimmerman, Robert; Ruiz, Sr., Rafael; Zhang, Sheng, Cyanoacrylate tissue adhesives.
  58. Zhang, Sheng; Ruiz, Sr., Rafael; Azevedo, Max, Cyanoacrylate tissue adhesives with desirable permeability and tensile strength.
  59. Zhang, Sheng; Ruiz, Rafael, Cyanoacrylate-based liquid microbial sealant drape.
  60. Kuzma, Petr; Decker, Stefanie, Delivery of dry formulations of octreotide.
  61. Dalby, Brian; Bennett, Robert P., Delivery of functional protein sequences by translocating polypeptides.
  62. David B. Masters, Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices.
  63. Shih, Jason; Brennan, Jeffrey; Jiang, Fukang; Caffey, Sean, Drug-delivery pump with dynamic, adaptive control.
  64. Li, Po-Ying; Li, Shengtao; Lee, Jonathan K.; Ryan, Patrick; Lai, Alice; Caffey, Sean; Humayun, Mark S., Drug-delivery pump with intelligent control.
  65. Li, Po-Ying; Li, Shengtao; Lee, Jonathan K.; Ryan, Patrick; Lai, Alice; Caffey, Sean; Humayun, Mark S., Drug-delivery pump with intelligent control.
  66. Pang, Changlin; Jiang, Fukang; Shih, Jason; Caffey, Sean; Humayun, Mark S.; Tai, Yu-Chong, Drug-delivery pumps and methods of manufacture.
  67. Pang, Changlin; Jiang, Fukang; Shih, Jason; Caffey, Sean; Humayun, Mark S.; Tai, Yu-Chong, Drug-delivery pumps and methods of manufacture.
  68. Pang, Changlin; Jiang, Fukang; Shih, Jason; Caffey, Sean; Humayun, Mark; Tai, Yu-Chong, Drug-delivery pumps and methods of manufacture.
  69. Pang, Changlin; Jiang, Fukang; Shih, Jason; Caffey, Sean; Humayun, Mark; Tai, Yu-Chong, Drug-delivery pumps and methods of manufacture.
  70. Pang, Changlin; Jiang, Fukang; Shih, Jason; Caffey, Sean; Humayun, Mark; Tai, Yu-Chong, Drug-delivery pumps and methods of manufacture.
  71. Pang, Changlin; Jiang, Fukang; Shih, Jason; Caffey, Sean; Humayun, Mark; Tai, Yu-Chong, Drug-delivery pumps and methods of manufacture.
  72. Pang, Changlin; Jiang, Fukang; Shih, Jason; Caffey, Sean; Humayun, Mark; Tai, Yu-Chong; Brennan, Jeffrey; Peck, Raymond, Drug-delivery pumps and methods of manufacture.
  73. Shih, Jason; Brennan, Jeffrey; Jiang, Fukang; Caffey, Sean, Drug-delivery pumps with dynamic, adaptive control.
  74. Masters, David B.; Berg, Eric P., Encapsulated or coated stent systems.
  75. Rakic, Jean-Marie; Foidart, Jean-Michel, Eye device.
  76. Doud, Darren; Campbell, Randolph E.; Erickson, Signe; MacFarlane, K. Angela; Barrett, Mike; Skieller, Christina; Batten, David; Stine, Greg; de Juan, Jr., Eugene; Sutton, Douglas; Farinas, Kathleen Cogan, Fluid exchange apparatus and methods.
  77. Charles, Matthew, Formulations of human tissue kallikrein-1 for parenteral delivery and related methods.
  78. Gong, Glen; Pai, Suresh Subraya; Sershen, Scott Robert, Fragmented hydrogels.
  79. Tsibris John C. M. ; Porter Kathy B., Guinea pig model for leiomyomas.
  80. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark, Human tissue kallikrein 1 glycosylation isoforms.
  81. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark, Human tissue kallikrein 1 glycosylation isoforms.
  82. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  83. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  84. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  85. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  86. Petr Kuzma ; Harry Quandt, Hydrogel compositions useful for the sustained release of macromolecules and methods of making same.
  87. Katti Kattesh V. ; Karra Srinivasa Rao ; Berning Douglas E. ; Smith C. Jeffrey ; Volkert Wynn A. ; Ketring Alan R., Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same.
  88. Katti Kattesh V. ; Karra Srinivasa Rao ; Berning Douglas E. ; Smith C. Jeffrey ; Volkert Wynn A. ; Ketring Alan R., Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same.
  89. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related implants.
  90. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  91. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  92. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  93. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  94. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  95. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  96. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  97. Hughes, Patrick M., Hypotensive prostamide-containing biodegradable intraocular implants and related methods.
  98. Hadden, John W., Immunotherapy for reversing immune suppression.
  99. Kuzma, Petr; Decker, Stephanie; Quandt, Harry, Implant device release agents and methods of using same.
  100. Adamis, Anthony P.; Miller, Joan W.; Gragoudas, Evangelos S.; Mescher, Mark J.; Dubé, Christopher E.; Borenstein, Jeffrey T.; Weinstein, Marcie G.; Miller, Raanan A.; Hansberry, Mitchell L., Implantable drug delivery device and use thereof.
  101. Rodstrom, Theron Robert, Implantable drug delivery system.
  102. Humayun, Mark; Tai, Yu-Chong; Jelisavcic, Nenad; Kavazov, Julian D.; Jiang, Fukang, Implantable drug pumps and refill devices therefor.
  103. Tai, Yu-Chong; Shih, Jason; Kavazov, Julian D., Implantable drug pumps and refill devices therefor.
  104. Shih, Jason; Pang, Changlin; Jiang, Fukang; Caffey, Sean; Humayun, Mark; Tai, Yu-Chong; Peck, Raymond, Implantable drug-delivery devices, and apparatus and methods for filling the devices.
  105. Shih, Jason; Pang, Changlin; Jiang, Fukang; Caffey, Sean; Humayun, Mark; Tai, Yu-Chong; Peck, Raymond, Implantable drug-delivery devices, and apparatus and methods for filling the devices.
  106. Shih, Jason; Tai, Yu-Chong; Pang, Changlin; Caffey, Sean; Peck, Raymond; Jiang, Fukang; Humayun, Mark, Implantable drug-delivery devices, and apparatus and methods for filling the devices.
  107. Meng, Ellis Fan-chuin; Humayun, Mark S.; Lo Mann, Ronalee; Li, Po-Ying; Saati, Saloomeh, Implantable drug-delivery devices, and apparatus and methods for refilling the devices.
  108. Meng, Ellis Fan-chuin; Chen, Po-Jui; Rodger, Damien C.; Tai, Yu-Chong; Humayun, Mark S., Implantable intraocular pressure drain.
  109. Li, Jianmin; Conley, Danielle; Bucay-Couto, Weenna; Dao, Cang Duy; Davoudi, Hamid; Lareau, Raymond J.; Miller, Kathleen M, Implantable or insertable medical devices for controlled drug delivery.
  110. Li, Jianmin; Conley, Danielle; Couto, Weenna Bucay; Dao, Cang Duy; Davoudi, Hamid; Lareau, Raymond; Miller, Kathleen M., Implantable or insertable medical devices for controlled drug delivery.
  111. Pang, Changlin; Shih, Jason; Jiang, Fukang; Caffey, Sean; Humayun, Mark; Tai, Yu-Chong, Implantable pumps and cannulas therefor.
  112. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E., Implantable therapeutic device.
  113. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E., Implantable therapeutic device.
  114. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E., Implantable therapeutic device.
  115. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  116. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  117. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  118. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  119. Chou, Kang-Jye; Guo, Hong; Ashton, Paul; Shimizu, Robert W.; Watson, David A., Injectable sustained release delivery devices.
  120. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E.; Doud, Darren; Erickson, Signe; Barrett, Mike; Batten, David; Skieller, Christina; Stine, Greg, Injector apparatus and method for drug delivery.
  121. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E.; Doud, Darren; Erickson, Signe; Barrett, Mike; Batten, David; Skieller, Christina; Stine, Greg, Injector apparatus and method for drug delivery.
  122. de Juan, Jr., Eugene; Erickson, Signe; Campbell, Randolph E.; Doud, Darren; Barrett, Michael; Batten, David; Skieller, Christina; Stine, Greg, Injector apparatus and method for drug delivery.
  123. de Juan, Jr., Eugene; Campbell, Randolph E.; Erickson, Signe; Barrett, Mike; Skieller, Christina; Batten, David; Doud, Darren, Insertion and removal methods and apparatus for therapeutic devices.
  124. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michele, Intraocular biodegradable microspheres.
  125. Robinson, Michael R.; Blanda, Wendy M.; Hughes, Patrick M.; Ruiz, Guadalupe; Orilla, Werhner C.; Whitcup, Scott M.; Welty, Devin F.; Lin, Joan-En; Spada, Lon T., Intraocular drug delivery systems.
  126. Novakovic, Zoran; Bhagat, Rahul; Davis, Shawn R., Intraocular injector.
  127. Hughes, Patrick M., Intraocular pressure reduction with intracameral bimatoprost implants.
  128. Spada, Lon T.; Shiah, Jane Guo; Hughes, Patrick; Malone, Thomas C.; Devries, Gerald W.; Edelman, Jeffrey L.; Wurster, Julie A.; Guo, Xialing; Boral, Sougato, Kinase inhibitors.
  129. Zhang, Sheng; Ruiz, Sr., Rafael, Low dose gamma sterilization of liquid adhesives.
  130. Meng, Ellis; Tai, Yu-Chong; Humayun, Mark S.; Agrawal, Rajat; Lo, Ronalee; Shih, Jason; Kuwahara, Kenrick; Li, Po-Ying; Rodger, Damien; Chen, Po-Jui, MEMS device and method for delivery of therapeutic agents.
  131. Meng, Ellis; Tai, Yu-Chong; Humayun, Mark; Agrawal, Rajat; Lo, Ronalee; Shih, Jason; Kuwahara, Kenrick; Li, Po-Ying; Rodger, Damien; Chen, Po-Jui, MEMS device and method for delivery of therapeutic agents.
  132. Tai, Yu-Chong; Humayun, Mark; Shih, Jason, MEMS device and method for delivery of therapeutic agents.
  133. Tai, Yu-Chong; Humayun, Mark; Shih, Jason, MEMS device and method for delivery of therapeutic agents.
  134. Chappa, Ralph A., Medical devices and methods for producing the same.
  135. Bucay-Couto, Weenna, Medical imaging reference devices.
  136. Silvia S. Jurisson ; Thomas P. Quinn ; Michael F. Giblin, Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma.
  137. Vardimon Lily,ILX, Method and composition for treating neuronal degeneration.
  138. Harpal S. Mangat ; Gerry Ballough ; Gary Brown, Method and composition for treatment of ischemic neuronal reperfusion injury.
  139. Norman ; Jr. James G., Method for decreasing severity of acute and chronic pancreatitis.
  140. Wong, Vernon G, Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  141. Wong, Vernon G., Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  142. Wong, Vernon G., Method for reducing transplant rejection in the eye and intraocular implants for use therefor.
  143. Zuckerman,Kenneth S.; Liu,Richard Y., Method for the inhibition of function of STAT transcription factors.
  144. Zuckerman, Kenneth S.; Liu, Richard Y., Method for the modulation of function of transcription factors.
  145. Zuckerman,Kenneth S.; Liu,Richard Y., Method for the modulation of function of transcription factors.
  146. Ashton, Paul, Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
  147. Shyam S. Mohapatra ; Hiroto Matsuse ; Aruna K. Behera ; Mukesh Kumar, Method of intranasal gene transfer for protection against respiratory infection.
  148. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Method of making oil-in-oil emulsified polymeric implants containing a hypotensive lipid.
  149. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michèle, Method of making tyrosine kinase microspheres.
  150. Kuzma, Petr; Decker, Stefanie; Quandt, Harry, Method of manufacturing an implantable device.
  151. Kuzma, Petr; Decker, Stefanie; Quandt, Harry, Method of manufacturing an implantable device.
  152. Zhang, Sheng; Ruiz, Rafael, Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator.
  153. Weber, David A.; Kane, Ingrid; Rehal, Mike; Lathrop, Robert L.; Aptekarev, Kenny; Etter, Jeffrey, Methods and apparatus for delivery of ocular implants.
  154. Weber,David A.; Kane,Ingrid; Rehal,Mike; Lathrop, III,Robert L.; Aptekarev,Kenny; Etter,Jeffrey, Methods and apparatus for delivery of ocular implants.
  155. Chesnut, Jonathan D.; Carrino, John; Leong, Louis; Madden, Knut; Gleeson, Martin; Fan, James; Brasch, Michael; Cheo, David; Hartley, James L.; Byrd, Devon R.; Temple, Gray F., Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites.
  156. Chesnut, Jonathan; Carrino, John; Leong, Louis; Madden, Knut; Gleeson, Martin; Fan, James; Brasch, Michael; Cheo, David; Hartley, James; Byrd, Devon; Temple, Gary, Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites.
  157. Chesnut,Jonathan D.; Carrino,John; Leong,Louis; Madden,Knut; Gleeson,Martin A. G.; Fan,James; Brasch,Michael A.; Cheo,David; Hartley,James L.; Byrd,Devon R. N.; Temple,Gary F., Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites.
  158. Chestnut,Jonathan D.; Carrino,John; Leong,Louis; Madden,Knut; Gleeson,Martin; Fan,James; Brasch,Michael A.; Cheo,David; Hartley,James L.; Byrd,Devon R.N.; Temple,Gary F., Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites.
  159. Chesnut, Jonathan; Carrino, John; Leong, Louis; Madden, Knut; Gleeson, Martin; Fan, James; Brasch, Michael; Cheo, David; Hartley, James; Byrd, Devon; Temple, Gary, Methods and compositions for synthesis of nucleic acid molecules using multiplerecognition sites.
  160. Levy, Efrat, Methods and compositions relating to cystatin C.
  161. Wong, Vernon G., Methods for reducing edema.
  162. Wong, Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use.
  163. Wong, Vernon G, Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  164. Wong, Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  165. Wong,Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  166. De Colle, Cyril; Pasricha, Pankaj, Methods for treating GI tract disorders.
  167. De Colle, Cyril; Pasricha, Pankaj, Methods for treating GI tract disorders.
  168. Wong, Vernon G., Methods for treating edema in the eye and intraocular implants for use therefor.
  169. Wong, Vernon G., Methods for treating edema in the eye and intraocular implants for use therefor.
  170. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  171. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  172. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  173. Feinstein,Elena; Mor,Orna, Methods of diagnosing bladder cancer.
  174. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Methods of treating ocular disease using steroid-containing sustained release intraocular implants.
  175. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Microparticles manufactured in an oil-in-water process comprising a prostamide.
  176. Guyon, Thierry; Borrelly, Gilles; Drittanti, Lila; Vega, Manuel, Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof.
  177. Jin, Xiaomei; Yu, Lei; Takahashi, Hirokazu; Tanaka, Yasunobu; Niitsu, Yoshiro; Feinstein, Elena; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor; Erlich, Shai; Squiers, Elizabeth C.; Chen, Ning, Modulation of HSP47 expression.
  178. Jin, Xiaomei; Yu, Lei; Takahashi, Hirokazu; Tanaka, Yasunobu; Niitsu, Yoshiro; Feinstein, Elena; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor; Erlich, Shai; Squiers, Elizabeth C; Chen, Ning, Modulation of HSP47 expression.
  179. Jin, Xiaomei; Yu, Lei; Takahashi, Hirokazu; Tanaka, Yasunobu; Niitsu, Yoshiro; Feinstein, Elena; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor; Erlich, Shai; Squiers, Elizabeth C; Chen, Ning, Modulation of HSP47 expression.
  180. Paris, Daniel; Town, Terrence C.; Mullan, Michael J., Modulation of the phospholipase A2 pathway as a therapeutic.
  181. Masters, David B.; Berg, Eric P., Mucoadhesive drug delivery devices and methods of making and using thereof.
  182. Jarvis, Gary A.; John, Constance M.; Leffler, Hakon, N-terminally truncated galectin-3 for use in treating cancer.
  183. Chopp, Michael; Zhang, Rui Lan, Nitric oxide donors for inducing neurogenesis.
  184. Chopp, Michael; Zhang, Rui Lan, Nitric oxide donors for inducing neurogenesis.
  185. Chopp,Michael; Zhang,Rui Lan, Nitric oxide donors for inducing neurogenesis.
  186. Chesnut, Jon; Leong, Louis, Nucleic acid molecules containing recombination sites and methods of using the same.
  187. Chesnut, Jonathan; Leong, Louis, Nucleic acid molecules containing recombination sites and methods of using the same.
  188. Kuzma, Petr; Decker, Stefanie; Quandt, Harry, Octreotide implant having a release agent.
  189. Trogden, John T.; Lyons, Robert T.; Chang, James N.; Robinson, Michael R.; Orilla, Werhner C., Ocular implant delivery assemblies with distal caps.
  190. Bianchi, Keith; Hartsig, Bill; Nunn, Scott; Patel, Mukund; Sponsel, Mark; Vedrine, Lionel; Waitz, Ariel, Ocular implant delivery device and method.
  191. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  192. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  193. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  194. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  195. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  196. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  197. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  198. Highley, Brian; Beeson, Morgan; Jackson, Randy; Wayman, Christopher Edward; Shetler, Lance; Cutino, Antonio; Wright, Michael Thomas, Ocular implantation device.
  199. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and prostamide.
  200. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  201. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  202. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  203. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  204. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  205. Feinstein, Elena; Adamsky, Svetlana; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor, Oligonucleotide modulators of the toll-like receptor pathway.
  206. Feinstein, Elena; Adamsky, Svetlana; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor, Oligonucleotide modulators of the toll-like receptor pathway.
  207. Chauhan, Anuj; Gulsen, Derya, Ophthalmic drug delivery system.
  208. Erickson, Signe; Campbell, Randolph E.; Doud, Darren, Ophthalmic implant for delivering therapeutic substances.
  209. Haapakumpu,Timo; Jukarainen,Harri; Ala Sorvari,Juha; Rankonen,Henry; Riphagen,Frederik E.; Arnold,Wolfgang, Otorhinological delivery device.
  210. Richard Y. Liu ; Kenneth S. Zuckerman, Peptide antagonists of tumor necrosis factor alpha.
  211. Hawley-Nelson, Pamela; Lan, Jianqing; Shih, PoJen; Jessee, Joel A.; Schifferli, Kevin P.; Gebeyehu, Gulilat; Ciccarone, Valentina C.; Evans, Krista L., Peptide-enhanced transfections.
  212. Lyons, Robert T.; Robinson, Michael R.; Trogden, John T.; Whitcup, Scott M., Peripherally administered viscous formulations.
  213. Whitcup, Scott M.; Robinson, Michael R.; Lyons, Robert T.; Trogden, John T., Peripherally administered viscous formulations.
  214. Lyons, Robert T.; Chang, James N.; Trogden, John T.; Whitcup, Scott, Pharmaceutical compositions.
  215. Gong, Glen; Pai, Suresh Subraya; Sershen, Scott Robert, Polysaccharide based hydrogels.
  216. Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Farinas, Kathleen C., Posterior segment drug delivery.
  217. Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Farinas, Kathleen C., Posterior segment drug delivery.
  218. de Juan, Jr., Eugene; Alster, Yair; Chamow, Steven M.; Farinas, Kathleen Cogan; Giffor, III, Hanson S.; MacFarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; George, Robert; Sutton, Douglas, Posterior segment drug delivery.
  219. de Juan, Jr., Eugene; Alster, Yair; Chamow, Steven M.; Farinas, Kathleen Cogan; Gifford, III, Hanson S.; Macfarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; George, Robert; Sutton, Douglas, Posterior segment drug delivery.
  220. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; Gifford, III, Hanson S.; MacFarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Sutton, Douglas, Posterior segment drug delivery.
  221. de Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; Gifford, III, Hanson S.; MacFarlane, K. Angela; Reich, Cary J.; Barrett, Michael; Campbell, Randolph E.; Sutton, Douglas, Posterior segment drug delivery.
  222. de Juan, Jr., Eugene; Alster, Yair; Gifford, III, Hanson S.; Barrett, Michael; Campbell, Randolph E.; Sutton, Douglas, Posterior segment drug delivery.
  223. De Colle, Cyril; Pasricha, Pankaj; Wustrow, David, Prodrugs of metopimazine.
  224. Masters, David B., Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof.
  225. Masters, David B.; Berg, Eric P., Protein biomaterials and biocoacervates and methods of making and using thereof.
  226. Masters, David B.; Berg, Eric P., Protein biomaterials and biocoacervates and methods of making and using thereof.
  227. Masters, David B., Protein matrix materials, devices and methods of making and using thereof.
  228. Masters, David B., Protein matrix materials, devices and methods of making and using thereof.
  229. Wilk, Bogdan Kazimierz; Rubezhov, Arkadiy Zinoviy; Hadfield, Anthony Francis; Helom, Jean Louise, Purification of progesterone receptor modulators.
  230. Wilk, Bogdan Kazimierz; Rubezhov, Arkadiy Zinoviy; Hadfield, Anthony Francis; Helom, Jean Louise, Purification of progesterone receptor modulators.
  231. Wilk, Bogdan Kazimierz; Rubezhov, Arkadiy Zinoviy; Hadfield, Anthony Francis; Helom, Jean Louise, Purification of progesterone receptor modulators.
  232. Hartley,James L.; Brasch,Michael A., Recombinational cloning using engineered recombination sites.
  233. Hartley,James L.; Brasch,Michael A., Recombinational cloning using engineered recombination sites.
  234. Hartley,James L.; Brasch,Michael A., Recombinational cloning using engineered recombination sites.
  235. Fox, Donna; Temple, Gary; Hartley, James; Brasch, Michael, Recombinational cloning using nucleic acids having recombination sites.
  236. Hartley,James L.; Brasch,Michael A.; Temple,Gary F.; Fox,Donna K., Recombinational cloning using nucleic acids having recombination sites.
  237. Varner, Signe Erickson; De Juan, Eugene; Barnes, Aaron Christopher; Shelley, Terry Harrison; Cooney, Michael J., Reservoir device for intraocular drug delivery.
  238. Varner, Signe Erickson; Dejuan, Eugene; Barnes, Aaron Christopher; Shelley, Terry Harrison; Cooney, Michael J., Reservoir device for intraocular drug delivery.
  239. Varner, Signe Erickson; de Juan, Jr., Eugene; Barnes, Aaron Christopher; Shelley, Terry Harrison; Cooney, Michael J., Reservoir device for intraocular drug delivery.
  240. De Juan, Jr., Eugene; Alster, Yair; Farinas, Kathleen Cogan; MacFarlane, K. Angela; Reich, Cary J.; Campbell, Randolph E.; Erickson, Signe, Small molecule delivery with implantable therapeutic device.
  241. Horvath, Judit; Astafieva, Irina; Erickson, Signe; Farinas, Kathleen Cogan, Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof.
  242. Horvath, Judit; Astafieva, Irina; Erickson, Signe; Farinas, Kathleen Cogan, Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof.
  243. Zhang, Sheng; Ruiz, Rafael, Stable and sterile tissue adhesive composition with a controlled high viscosity.
  244. Huang, Leaf; Gao, Xiang; Sorgi, Frank L., Stable lipid-comprising drug delivery complexes and methods for their production.
  245. Huang, Leaf; Gao, Xiang; Sorgi, Frank L., Stable lipid-comprising drug delivery complexes and methods for their production.
  246. Huang, Leaf; Gao, Xiang; Sorgi, Frank L., Stable lipid-comprising drug delivery complexes and methods for their production.
  247. Zhang, Sheng; Ruiz, Sr., Rafael; Phelps, Shannon, Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides.
  248. Zhang, Sheng; Ruiz, Sr., Rafael, Sterilized liquid compositions of cyanoacrylate monomer mixtures.
  249. Zhang, Sheng; Ruiz, Sr., Rafael, Sterilized liquid compositions of cyanoacrylate monomer mixtures.
  250. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  251. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  252. Robinson, Michael R.; Whitcup, Scott M., Steroid-containing sustained release intraocular implants and related methods.
  253. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  254. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  255. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  256. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  257. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  258. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  259. Hong Guo ; Paul Ashton, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  260. Burke, James; Hughes, Patrick M.; Werhner, Orilla C.; Lin, Ton C.; Escobar, Maria; Huang, Glenn; Zhang, Kai-Ming; Wheeler, Larry A.; Donn, Rosy S., Sustained release intraocular implants and methods for preventing retinal dysfunction.
  261. Huang, Glenn T.; Burke, James A.; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Sheng, Rosy, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  262. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  263. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  264. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and methods for treating ocular neuropathies.
  265. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  266. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  267. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  268. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  269. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  270. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  271. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  272. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  273. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  274. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  275. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  276. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffrey L.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  277. Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Edelman, Jeffrey L.; Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  278. Astafieva, Irina; Horvath, Judit; Farinas, Kathleen Cogan; Bueche, Blaine; Erickson, Signe, Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant.
  279. Wilk, Bogdan Kazimierz, Thioamide derivatives as progesterone receptor modulators.
  280. Wilk, Bogdan Kazimierz, Thioamide derivatives as progesterone receptor modulators.
  281. Wilk,Bogdan Kazimierz, Thioamide derivatives as progesterone receptor modulators.
  282. Wilk,Bogdan Kazimierz, Thioamide derivatives as progesterone receptor modulators.
  283. Chu, Yongliang; Masoud, Malek; Gebeyehu, Gulilat, Transfection reagents.
  284. Chu, Yongliang; Masoud, Malek; Gebeyehu, Gulilat, Transfection reagents.
  285. Chu, Yongliang; Masoud, Malek; Gebeyehu, Gulilat, Transfection reagents.
  286. Chu, Yongliang; Masoud, Malek; Gebeyehu, Gulilat, Transfection reagents.
  287. Chu,Yongliang; Masoud,Malek; Gebeyehu,Gulilat, Transfection reagents.
  288. Chu,Yongliang; Masoud,Malek; Gebeyehu,Gulilat, Transfection reagents.
  289. Chu,Yongliang; Masoud,Malek; Gebeyehu,Gulilat, Transfection reagents.
  290. Chu,Yongliang; Masoud,Malek; Gebeyehu,Gulilat, Transfection reagents.
  291. Ebert, Charles D.; Sanders, Steven W., Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy.
  292. Cheo,David; Brasch,Michael A.; Temple,Gary F.; Hartley,James L.; Byrd,Devon R. N., Use of multiple recombination sites with unique specificity in recombinational cloning.
  293. Cheo,David; Brasch,Michael A.; Temple,Gary F.; Hartley,James L.; Byrd,Devon R. N., Use of multiple recombination sites with unique specificity in recombinational cloning.
  294. Hadden, John W.; Signorelli, Kathy; Egan, James, Vaccine immunotherapy.
  295. Hadden, John W., Vaccine immunotherapy for immune suppressed patients.
  296. Hadden,John W., Vaccine immunotherapy for immune suppressed patients.
  297. Masters, David B.; Berg, Eric P., Wound treatments with crosslinked protein amorphous biomaterials.
  298. Perera, Ranjan, miR-211 expression and related pathways in human melanoma.

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로